India’s Serum Institute of India, the world’s busiest vaccine manufacturer as measured by volume, emerges as a worldwide key player in the battle against COVID-19. A major partnership was put together thanks to Gavi, The Vaccine Alliance, the Bill & Melinda Gates Foundation, and Serum Institute of India. The initial seed funding will be injected into Serum Institute of India to commence “at-risk” vaccine candidate manufacturing to accelerate the production of up to 100 million doses of COVID-19 vaccines for India and other low to middle-income countries (LMICs).
The world’s largest vaccine maker by volume, Serum Institute of India, reports a landmark deal with GAVI, The Vaccine Alliance, and the Bill & Melinda Gates Foundation in a bid to accelerate the production and distribution of up to 100 million doses of COVID-19 vaccines for India and low to middle-income countries, also known as LMICs.
Not all details were shared, but what is known is that Gavi, The Vaccine Alliance, and the Bill & Melinda Gates Foundation will inject capital (including $150m from Gates) into the Serum Institute of India to augment the manufacturing capacity currently, enabl...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).